Cargando…
An engineered biosynthetic–synthetic platform for production of halogenated indolmycin antibiotics
Indolmycin is an antibiotic from Streptomyces griseus ATCC 12648 with activity against Helicobacter pylori, Plasmodium falciparum, and methicillin-resistant Staphylococcus aureus. Here we describe the use of the indolmycin biosynthetic genes in E. coli to make indolmycenic acid, a chiral intermediat...
Autores principales: | Hoffarth, Elesha R., Kong, Sunnie, He, Hai-Yan, Ryan, Katherine S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246080/ https://www.ncbi.nlm.nih.gov/pubmed/34257882 http://dx.doi.org/10.1039/d0sc05843b |
Ejemplares similares
-
Correction: An engineered biosynthetic–synthetic platform for production of halogenated indolmycin antibiotics
por: Hoffarth, Elesha R., et al.
Publicado: (2021) -
Production of the Bioactive Compounds Violacein and Indolmycin Is Conditional in a maeA Mutant of Pseudoalteromonas luteoviolacea S4054 Lacking the Malic Enzyme
por: Thøgersen, Mariane S., et al.
Publicado: (2016) -
Post-synthetic halide conversion and selective halogen capture in hybrid perovskites
por: Solis-Ibarra, D., et al.
Publicado: (2015) -
Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering
por: Groß, Sebastian, et al.
Publicado: (2021) -
Deacetylation of mycothiol-derived ‘waste product’ triggers the last biosynthetic steps of lincosamide antibiotics
por: Kamenik, Zdenek, et al.
Publicado: (2016)